about
Immunohistochemical expression of CXCR4 on breast cancer and its clinical significanceAbsence of Association between CCR5 rs333 Polymorphism and Childhood Acute Lymphoblastic Leukemia.CXCL12/CXCR4 axis in the pathogenesis of acute lymphoblastic leukemia (ALL): a possible therapeutic target.Changes in gene expression in PBMCs profiles of PPARα target genes in obese and non-obese individuals during fasting.Interleukin 7 receptor alpha Thr244Ile genetic polymorphism is associated with susceptibility and prognostic markers in breast cancer subgroups.The effect of propolis on CCL5 and IFN-γ expression by peripheral blood mononuclear cells from leishmaniasis patients.Expression of noncoding mRNA in human blood cells activated with synthetic peptide of HIVAssociation study of CCR5 delta 32 polymorphism among the HLA-DRB1 Caucasian population in Northern Paraná, BrazilIL-10 gene polymorphism and influence of chemotherapy on cytokine plasma levels in childhood acute lymphoblastic leukemia patients: IL-10 polymorphism and plasma levels in leukemia patientsPotential use of CXCL12/CXCR4 and sonic hedgehog pathways as therapeutic targets in medulloblastomaCCL5 protein level: influence on breast cancer staging and lymph nodes commitmentGermline APOBEC3B deletion influences clinicopathological parameters in luminal-A breast cancer: evidences from a southern Brazilian cohort
P50
Q27011420-DD9413E7-D28F-48F3-BCC8-43DBE1297E21Q33562659-C4EC21E5-D214-4E80-A27E-5904D9A8CF87Q38311811-1641A72C-5983-4494-8FF9-A2D2A3690236Q42470191-A80D5631-3AF1-4917-A903-A2B4323094E2Q47892947-E8B54161-355F-4DAF-BCC5-D58E65221FE0Q54335061-10D9DED9-567F-478F-9277-12149453A44DQ80388851-D76D7F0D-6C30-41E4-91DA-2B6D3DDAB6CDQ81632719-AF1AEE8E-FBF6-4B82-9FE3-39897DB10316Q85528100-40824F3C-74F7-46EF-BDB2-0602AAFDA1B2Q88711529-2E0ABE95-1B34-4FEB-9FEE-70DAEEC2A0BAQ91131379-BC1E4BE8-D599-488E-8C6C-8C5A07538A56Q91881651-E069548B-1254-4466-A285-F6799DA688E5
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Marla Karine Amarante
@ast
Marla Karine Amarante
@en
Marla Karine Amarante
@es
Marla Karine Amarante
@nl
Marla Karine Amarante
@sl
type
label
Marla Karine Amarante
@ast
Marla Karine Amarante
@en
Marla Karine Amarante
@es
Marla Karine Amarante
@nl
Marla Karine Amarante
@sl
prefLabel
Marla Karine Amarante
@ast
Marla Karine Amarante
@en
Marla Karine Amarante
@es
Marla Karine Amarante
@nl
Marla Karine Amarante
@sl
P106
P21
P31
P496
0000-0001-8218-8518